ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Paclitaxel Injection Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-5J4435
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Paclitaxel Injection Market Research Report 2021
BUY CHAPTERS

Global Paclitaxel Injection Market Research Report 2024

Code: QYRE-Auto-5J4435
Report
January 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch

Paclitaxel Injection Market Size

The global Paclitaxel Injection market was valued at US$ 3384 million in 2023 and is anticipated to reach US$ 7130.2 million by 2030, witnessing a CAGR of 11.1% during the forecast period 2024-2030.

Paclitaxel Injection Market

Paclitaxel Injection Market

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.
Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.
Global Paclitaxel Injection key players include Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Luye Pharma, etc. Global top five players hold a share about 80%.
Europe is the largest market, with a share about 25%, followed by North America and China, having a total share about 40 percent.
In terms of product, 5ml,30mg is the largest segment, with a share about 75%. And in terms of application, the largest application is Ovarian Cancer, followed by Breast Cancer, Cervical Cancer, Pancreatic Cancer.
This report aims to provide a comprehensive presentation of the global market for Paclitaxel Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel Injection.

Report Scope

The Paclitaxel Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paclitaxel Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paclitaxel Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Paclitaxel Injection Market Report

Report Metric Details
Report Name Paclitaxel Injection Market
Accounted market size in 2023 US$ 3384 million
Forecasted market size in 2030 US$ 7130.2 million
CAGR 11.1%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • 5ml,30mg
  • 10ml,60mg
  • 16.7ml,100mg
  • 25ml,150mg
  • 50ml,300mg
Segment by Application
  • Ovarian Cancer
  • Breast Cancer
  • Cervical Cancer
  • Pancreatic Cancer
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Taj Accura, Khandelwal Laboratories, Luye Pharma, Beijing Youcare, Beijing Union, Haiyao, Chuntch
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Paclitaxel Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Paclitaxel Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Paclitaxel Injection Market growing?

Ans: The Paclitaxel Injection Market witnessing a CAGR of 11.1% during the forecast period 2024-2030.

What is the Paclitaxel Injection Market size in 2030?

Ans: The Paclitaxel Injection Market size in 2030 will be US$ 7130.2 million.

What is the market share of major companies in Paclitaxel Injection Market?

Ans: Global top five players hold a share about 80%.

What is the Paclitaxel Injection Market share by type?

Ans: In terms of product, 5ml,30mg is the largest segment, with a share about 75%.

Who are the main players in the Paclitaxel Injection Market report?

Ans: The main players in the Paclitaxel Injection Market are Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Taj Accura, Khandelwal Laboratories, Luye Pharma, Beijing Youcare, Beijing Union, Haiyao, Chuntch

What are the Application segmentation covered in the Paclitaxel Injection Market report?

Ans: The Applications covered in the Paclitaxel Injection Market report are Ovarian Cancer, Breast Cancer, Cervical Cancer, Pancreatic Cancer, Other

What are the Type segmentation covered in the Paclitaxel Injection Market report?

Ans: The Types covered in the Paclitaxel Injection Market report are 5ml,30mg, 10ml,60mg, 16.7ml,100mg, 25ml,150mg, 50ml,300mg

1 Paclitaxel Injection Market Overview
1.1 Product Overview and Scope of Paclitaxel Injection
1.2 Paclitaxel Injection Segment by Type
1.2.1 Global Paclitaxel Injection Market Value Comparison by Type (2024-2030)
1.2.2 5ml,30mg
1.2.3 10ml,60mg
1.2.4 16.7ml,100mg
1.2.5 25ml,150mg
1.2.6 50ml,300mg
1.3 Paclitaxel Injection Segment by Application
1.3.1 Global Paclitaxel Injection Market Value by Application: (2024-2030)
1.3.2 Ovarian Cancer
1.3.3 Breast Cancer
1.3.4 Cervical Cancer
1.3.5 Pancreatic Cancer
1.3.6 Other
1.4 Global Paclitaxel Injection Market Size Estimates and Forecasts
1.4.1 Global Paclitaxel Injection Revenue 2019-2030
1.4.2 Global Paclitaxel Injection Sales 2019-2030
1.4.3 Global Paclitaxel Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Paclitaxel Injection Market Competition by Manufacturers
2.1 Global Paclitaxel Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Paclitaxel Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Paclitaxel Injection Average Price by Manufacturers (2019-2024)
2.4 Global Paclitaxel Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Paclitaxel Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Paclitaxel Injection, Product Type & Application
2.7 Paclitaxel Injection Market Competitive Situation and Trends
2.7.1 Paclitaxel Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Paclitaxel Injection Players Market Share by Revenue
2.7.3 Global Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Paclitaxel Injection Retrospective Market Scenario by Region
3.1 Global Paclitaxel Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Paclitaxel Injection Global Paclitaxel Injection Sales by Region: 2019-2030
3.2.1 Global Paclitaxel Injection Sales by Region: 2019-2024
3.2.2 Global Paclitaxel Injection Sales by Region: 2025-2030
3.3 Global Paclitaxel Injection Global Paclitaxel Injection Revenue by Region: 2019-2030
3.3.1 Global Paclitaxel Injection Revenue by Region: 2019-2024
3.3.2 Global Paclitaxel Injection Revenue by Region: 2025-2030
3.4 North America Paclitaxel Injection Market Facts & Figures by Country
3.4.1 North America Paclitaxel Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Paclitaxel Injection Sales by Country (2019-2030)
3.4.3 North America Paclitaxel Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Paclitaxel Injection Market Facts & Figures by Country
3.5.1 Europe Paclitaxel Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Paclitaxel Injection Sales by Country (2019-2030)
3.5.3 Europe Paclitaxel Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Paclitaxel Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Paclitaxel Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Paclitaxel Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Paclitaxel Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Paclitaxel Injection Market Facts & Figures by Country
3.7.1 Latin America Paclitaxel Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Paclitaxel Injection Sales by Country (2019-2030)
3.7.3 Latin America Paclitaxel Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Paclitaxel Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Paclitaxel Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Paclitaxel Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Paclitaxel Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Paclitaxel Injection Sales by Type (2019-2030)
4.1.1 Global Paclitaxel Injection Sales by Type (2019-2024)
4.1.2 Global Paclitaxel Injection Sales by Type (2025-2030)
4.1.3 Global Paclitaxel Injection Sales Market Share by Type (2019-2030)
4.2 Global Paclitaxel Injection Revenue by Type (2019-2030)
4.2.1 Global Paclitaxel Injection Revenue by Type (2019-2024)
4.2.2 Global Paclitaxel Injection Revenue by Type (2025-2030)
4.2.3 Global Paclitaxel Injection Revenue Market Share by Type (2019-2030)
4.3 Global Paclitaxel Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Paclitaxel Injection Sales by Application (2019-2030)
5.1.1 Global Paclitaxel Injection Sales by Application (2019-2024)
5.1.2 Global Paclitaxel Injection Sales by Application (2025-2030)
5.1.3 Global Paclitaxel Injection Sales Market Share by Application (2019-2030)
5.2 Global Paclitaxel Injection Revenue by Application (2019-2030)
5.2.1 Global Paclitaxel Injection Revenue by Application (2019-2024)
5.2.2 Global Paclitaxel Injection Revenue by Application (2025-2030)
5.2.3 Global Paclitaxel Injection Revenue Market Share by Application (2019-2030)
5.3 Global Paclitaxel Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporation Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol-Myers Squibb Paclitaxel Injection Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 Celgene Corporation
6.2.1 Celgene Corporation Corporation Information
6.2.2 Celgene Corporation Description and Business Overview
6.2.3 Celgene Corporation Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Celgene Corporation Paclitaxel Injection Product Portfolio
6.2.5 Celgene Corporation Recent Developments/Updates
6.3 Hospira
6.3.1 Hospira Corporation Information
6.3.2 Hospira Description and Business Overview
6.3.3 Hospira Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hospira Paclitaxel Injection Product Portfolio
6.3.5 Hospira Recent Developments/Updates
6.4 Biological E.
6.4.1 Biological E. Corporation Information
6.4.2 Biological E. Description and Business Overview
6.4.3 Biological E. Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biological E. Paclitaxel Injection Product Portfolio
6.4.5 Biological E. Recent Developments/Updates
6.5 Taj Accura
6.5.1 Taj Accura Corporation Information
6.5.2 Taj Accura Description and Business Overview
6.5.3 Taj Accura Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Taj Accura Paclitaxel Injection Product Portfolio
6.5.5 Taj Accura Recent Developments/Updates
6.6 Khandelwal Laboratories
6.6.1 Khandelwal Laboratories Corporation Information
6.6.2 Khandelwal Laboratories Description and Business Overview
6.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Khandelwal Laboratories Paclitaxel Injection Product Portfolio
6.6.5 Khandelwal Laboratories Recent Developments/Updates
6.7 Luye Pharma
6.6.1 Luye Pharma Corporation Information
6.6.2 Luye Pharma Description and Business Overview
6.6.3 Luye Pharma Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Luye Pharma Paclitaxel Injection Product Portfolio
6.7.5 Luye Pharma Recent Developments/Updates
6.8 Beijing Youcare
6.8.1 Beijing Youcare Corporation Information
6.8.2 Beijing Youcare Description and Business Overview
6.8.3 Beijing Youcare Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Beijing Youcare Paclitaxel Injection Product Portfolio
6.8.5 Beijing Youcare Recent Developments/Updates
6.9 Beijing Union
6.9.1 Beijing Union Corporation Information
6.9.2 Beijing Union Description and Business Overview
6.9.3 Beijing Union Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beijing Union Paclitaxel Injection Product Portfolio
6.9.5 Beijing Union Recent Developments/Updates
6.10 Haiyao
6.10.1 Haiyao Corporation Information
6.10.2 Haiyao Description and Business Overview
6.10.3 Haiyao Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Haiyao Paclitaxel Injection Product Portfolio
6.10.5 Haiyao Recent Developments/Updates
6.11 Chuntch
6.11.1 Chuntch Corporation Information
6.11.2 Chuntch Paclitaxel Injection Description and Business Overview
6.11.3 Chuntch Paclitaxel Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Chuntch Paclitaxel Injection Product Portfolio
6.11.5 Chuntch Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Paclitaxel Injection Industry Chain Analysis
7.2 Paclitaxel Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Paclitaxel Injection Production Mode & Process
7.4 Paclitaxel Injection Sales and Marketing
7.4.1 Paclitaxel Injection Sales Channels
7.4.2 Paclitaxel Injection Distributors
7.5 Paclitaxel Injection Customers
8 Paclitaxel Injection Market Dynamics
8.1 Paclitaxel Injection Industry Trends
8.2 Paclitaxel Injection Market Drivers
8.3 Paclitaxel Injection Market Challenges
8.4 Paclitaxel Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Khandelwal Laboratories
Luye Pharma
Beijing Youcare
Beijing Union
Haiyao
Chuntch
List of Tables
    Table 1. Global Paclitaxel Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Paclitaxel Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Paclitaxel Injection Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Paclitaxel Injection Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Paclitaxel Injection Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Paclitaxel Injection Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Paclitaxel Injection Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Paclitaxel Injection Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Paclitaxel Injection, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Paclitaxel Injection, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Paclitaxel Injection, Product Type & Application
    Table 12. Global Key Manufacturers of Paclitaxel Injection, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Paclitaxel Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel Injection as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Paclitaxel Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Paclitaxel Injection Sales by Region (2019-2024) & (K Units)
    Table 18. Global Paclitaxel Injection Sales Market Share by Region (2019-2024)
    Table 19. Global Paclitaxel Injection Sales by Region (2025-2030) & (K Units)
    Table 20. Global Paclitaxel Injection Sales Market Share by Region (2025-2030)
    Table 21. Global Paclitaxel Injection Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Paclitaxel Injection Revenue Market Share by Region (2019-2024)
    Table 23. Global Paclitaxel Injection Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Paclitaxel Injection Revenue Market Share by Region (2025-2030)
    Table 25. North America Paclitaxel Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Paclitaxel Injection Sales by Country (2019-2024) & (K Units)
    Table 27. North America Paclitaxel Injection Sales by Country (2025-2030) & (K Units)
    Table 28. North America Paclitaxel Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Paclitaxel Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Paclitaxel Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Paclitaxel Injection Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Paclitaxel Injection Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Paclitaxel Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Paclitaxel Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Paclitaxel Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Paclitaxel Injection Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Paclitaxel Injection Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Paclitaxel Injection Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Paclitaxel Injection Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Paclitaxel Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Paclitaxel Injection Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Paclitaxel Injection Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Paclitaxel Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Paclitaxel Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Paclitaxel Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Paclitaxel Injection Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Paclitaxel Injection Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Paclitaxel Injection Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Paclitaxel Injection Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Paclitaxel Injection Sales (K Units) by Type (2019-2024)
    Table 51. Global Paclitaxel Injection Sales (K Units) by Type (2025-2030)
    Table 52. Global Paclitaxel Injection Sales Market Share by Type (2019-2024)
    Table 53. Global Paclitaxel Injection Sales Market Share by Type (2025-2030)
    Table 54. Global Paclitaxel Injection Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Paclitaxel Injection Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Paclitaxel Injection Revenue Market Share by Type (2019-2024)
    Table 57. Global Paclitaxel Injection Revenue Market Share by Type (2025-2030)
    Table 58. Global Paclitaxel Injection Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Paclitaxel Injection Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Paclitaxel Injection Sales (K Units) by Application (2019-2024)
    Table 61. Global Paclitaxel Injection Sales (K Units) by Application (2025-2030)
    Table 62. Global Paclitaxel Injection Sales Market Share by Application (2019-2024)
    Table 63. Global Paclitaxel Injection Sales Market Share by Application (2025-2030)
    Table 64. Global Paclitaxel Injection Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Paclitaxel Injection Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Paclitaxel Injection Revenue Market Share by Application (2019-2024)
    Table 67. Global Paclitaxel Injection Revenue Market Share by Application (2025-2030)
    Table 68. Global Paclitaxel Injection Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Paclitaxel Injection Price (USD/Unit) by Application (2025-2030)
    Table 70. Bristol-Myers Squibb Corporation Information
    Table 71. Bristol-Myers Squibb Description and Business Overview
    Table 72. Bristol-Myers Squibb Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Bristol-Myers Squibb Paclitaxel Injection Product
    Table 74. Bristol-Myers Squibb Recent Developments/Updates
    Table 75. Celgene Corporation Corporation Information
    Table 76. Celgene Corporation Description and Business Overview
    Table 77. Celgene Corporation Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Celgene Corporation Paclitaxel Injection Product
    Table 79. Celgene Corporation Recent Developments/Updates
    Table 80. Hospira Corporation Information
    Table 81. Hospira Description and Business Overview
    Table 82. Hospira Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Hospira Paclitaxel Injection Product
    Table 84. Hospira Recent Developments/Updates
    Table 85. Biological E. Corporation Information
    Table 86. Biological E. Description and Business Overview
    Table 87. Biological E. Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Biological E. Paclitaxel Injection Product
    Table 89. Biological E. Recent Developments/Updates
    Table 90. Taj Accura Corporation Information
    Table 91. Taj Accura Description and Business Overview
    Table 92. Taj Accura Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Taj Accura Paclitaxel Injection Product
    Table 94. Taj Accura Recent Developments/Updates
    Table 95. Khandelwal Laboratories Corporation Information
    Table 96. Khandelwal Laboratories Description and Business Overview
    Table 97. Khandelwal Laboratories Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Khandelwal Laboratories Paclitaxel Injection Product
    Table 99. Khandelwal Laboratories Recent Developments/Updates
    Table 100. Luye Pharma Corporation Information
    Table 101. Luye Pharma Description and Business Overview
    Table 102. Luye Pharma Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Luye Pharma Paclitaxel Injection Product
    Table 104. Luye Pharma Recent Developments/Updates
    Table 105. Beijing Youcare Corporation Information
    Table 106. Beijing Youcare Description and Business Overview
    Table 107. Beijing Youcare Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Beijing Youcare Paclitaxel Injection Product
    Table 109. Beijing Youcare Recent Developments/Updates
    Table 110. Beijing Union Corporation Information
    Table 111. Beijing Union Description and Business Overview
    Table 112. Beijing Union Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Beijing Union Paclitaxel Injection Product
    Table 114. Beijing Union Recent Developments/Updates
    Table 115. Haiyao Corporation Information
    Table 116. Haiyao Description and Business Overview
    Table 117. Haiyao Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Haiyao Paclitaxel Injection Product
    Table 119. Haiyao Recent Developments/Updates
    Table 120. Chuntch Corporation Information
    Table 121. Chuntch Description and Business Overview
    Table 122. Chuntch Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. Chuntch Paclitaxel Injection Product
    Table 124. Chuntch Recent Developments/Updates
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. Paclitaxel Injection Distributors List
    Table 128. Paclitaxel Injection Customers List
    Table 129. Paclitaxel Injection Market Trends
    Table 130. Paclitaxel Injection Market Drivers
    Table 131. Paclitaxel Injection Market Challenges
    Table 132. Paclitaxel Injection Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Paclitaxel Injection
    Figure 2. Global Paclitaxel Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Paclitaxel Injection Market Share by Type in 2023 & 2030
    Figure 4. 5ml,30mg Product Picture
    Figure 5. 10ml,60mg Product Picture
    Figure 6. 16.7ml,100mg Product Picture
    Figure 7. 25ml,150mg Product Picture
    Figure 8. 50ml,300mg Product Picture
    Figure 9. Global Paclitaxel Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Paclitaxel Injection Market Share by Application in 2023 & 2030
    Figure 11. Ovarian Cancer
    Figure 12. Breast Cancer
    Figure 13. Cervical Cancer
    Figure 14. Pancreatic Cancer
    Figure 15. Other
    Figure 16. Global Paclitaxel Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Paclitaxel Injection Market Size (2019-2030) & (US$ Million)
    Figure 18. Global Paclitaxel Injection Sales (2019-2030) & (K Units)
    Figure 19. Global Paclitaxel Injection Average Price (USD/Unit) & (2019-2030)
    Figure 20. Paclitaxel Injection Report Years Considered
    Figure 21. Paclitaxel Injection Sales Share by Manufacturers in 2023
    Figure 22. Global Paclitaxel Injection Revenue Share by Manufacturers in 2023
    Figure 23. The Global 5 and 10 Largest Paclitaxel Injection Players: Market Share by Revenue in 2023
    Figure 24. Paclitaxel Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 25. Global Paclitaxel Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 26. North America Paclitaxel Injection Sales Market Share by Country (2019-2030)
    Figure 27. North America Paclitaxel Injection Revenue Market Share by Country (2019-2030)
    Figure 28. U.S. Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Canada Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Europe Paclitaxel Injection Sales Market Share by Country (2019-2030)
    Figure 31. Europe Paclitaxel Injection Revenue Market Share by Country (2019-2030)
    Figure 32. Germany Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. France Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. U.K. Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Italy Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Russia Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Asia Pacific Paclitaxel Injection Sales Market Share by Region (2019-2030)
    Figure 38. Asia Pacific Paclitaxel Injection Revenue Market Share by Region (2019-2030)
    Figure 39. China Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Japan Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. South Korea Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. India Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Australia Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Indonesia Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Thailand Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Malaysia Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Latin America Paclitaxel Injection Sales Market Share by Country (2019-2030)
    Figure 49. Latin America Paclitaxel Injection Revenue Market Share by Country (2019-2030)
    Figure 50. Mexico Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Brazil Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Argentina Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Middle East & Africa Paclitaxel Injection Sales Market Share by Country (2019-2030)
    Figure 54. Middle East & Africa Paclitaxel Injection Revenue Market Share by Country (2019-2030)
    Figure 55. Turkey Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. UAE Paclitaxel Injection Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 58. Global Sales Market Share of Paclitaxel Injection by Type (2019-2030)
    Figure 59. Global Revenue Market Share of Paclitaxel Injection by Type (2019-2030)
    Figure 60. Global Paclitaxel Injection Price (USD/Unit) by Type (2019-2030)
    Figure 61. Global Sales Market Share of Paclitaxel Injection by Application (2019-2030)
    Figure 62. Global Revenue Market Share of Paclitaxel Injection by Application (2019-2030)
    Figure 63. Global Paclitaxel Injection Price (USD/Unit) by Application (2019-2030)
    Figure 64. Paclitaxel Injection Value Chain
    Figure 65. Paclitaxel Injection Production Process
    Figure 66. Channels of Distribution (Direct Vs Distribution)
    Figure 67. Distributors Profiles
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions